Ken Griffin’s ProQR Therapeutics PRQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$774K Sell
379,263
-439,595
-54% -$897K ﹤0.01% 3586
2025
Q1
$1.09M Buy
818,858
+410,051
+100% +$545K ﹤0.01% 3186
2024
Q4
$1.08M Buy
408,807
+321,830
+370% +$853K ﹤0.01% 3182
2024
Q3
$158K Buy
86,977
+68,612
+374% +$125K ﹤0.01% 4745
2024
Q2
$30.5K Sell
18,365
-27,643
-60% -$45.9K ﹤0.01% 5309
2024
Q1
$104K Sell
46,008
-31,808
-41% -$72.2K ﹤0.01% 5065
2023
Q4
$154K Buy
+77,816
New +$154K ﹤0.01% 4720
2023
Q3
Sell
-116,792
Closed -$189K 6361
2023
Q2
$189K Buy
116,792
+17,013
+17% +$27.6K ﹤0.01% 4488
2023
Q1
$213K Buy
+99,779
New +$213K ﹤0.01% 4579
2022
Q4
Hold
0
6561
2022
Q3
Sell
-209,215
Closed -$162K 6512
2022
Q2
$162K Buy
+209,215
New +$162K ﹤0.01% 5086
2022
Q1
Sell
-222,269
Closed -$1.78M 6938
2021
Q4
$1.78M Buy
222,269
+130,063
+141% +$1.04M ﹤0.01% 3181
2021
Q3
$772K Buy
92,206
+34,076
+59% +$285K ﹤0.01% 4055
2021
Q2
$392K Buy
58,130
+29,754
+105% +$201K ﹤0.01% 4950
2021
Q1
$188K Buy
+28,376
New +$188K ﹤0.01% 5461
2020
Q4
Hold
0
5471
2020
Q3
Hold
0
5135
2020
Q2
Hold
0
5154
2020
Q1
Hold
0
5190
2019
Q4
Sell
-65,996
Closed -$380K 5000
2019
Q3
$380K Buy
65,996
+22,971
+53% +$132K ﹤0.01% 3686
2019
Q2
$391K Sell
43,025
-39,314
-48% -$357K ﹤0.01% 3697
2019
Q1
$1.14M Buy
82,339
+30,367
+58% +$421K ﹤0.01% 2736
2018
Q4
$819K Buy
+51,972
New +$819K ﹤0.01% 2916
2016
Q1
Sell
-11,960
Closed -$103K 3815
2015
Q4
$103K Sell
11,960
-1,676
-12% -$14.4K ﹤0.01% 3241
2015
Q3
$198K Buy
13,636
+634
+5% +$9.21K ﹤0.01% 3186
2015
Q2
$217K Buy
13,002
+3,405
+35% +$56.8K ﹤0.01% 3005
2015
Q1
$210K Buy
+9,597
New +$210K ﹤0.01% 3086
2014
Q4
Sell
-108,715
Closed -$1.87M 3956
2014
Q3
$1.87M Buy
+108,715
New +$1.87M ﹤0.01% 1619